Sorting it all Out: Serological Case Studies (Release date 10/09/2019) This course is designed to guide the learner through 3 commonly encountered serological challenges. Unexpected pre-transfusion test results, resolution and transfusion recommendations are discussed.  The cases include: a work-up with ‘non-specific’ reactivity, an ABO discrepancy work-up, and identification of anti-G in a pregnant woman.

Transfusion Related Respiratory Complications: An Update on TRALI, TACO and TAD (Release date 09/04/2019) European and U.S. hemovigilance programs have provided guidelines defining the various transfusion complications. The focus of this course is distinctions and similarities between the primary transfusion related respiratory complications and the hemovigilance definitions of TRALI, TACO and TAD.

Plasma Exchange Across the Pediatric ECMO Circuit (Release date 03/07/2019) The Extracorporeal Membrane Oxygenation (ECMO) is a therapeutic methodology used in patients with compromised lung function. The focus of this course is the use of plasma exchange during ECMO in treating pediatric patients. 

Platelet Refractoriness: Patient Evaluation and Product Selection (Release date 01/06/2020) This course defines platelet refractoriness and describes the relevant antigens. Antigen typing and testing are reviewed. Finally, this educational session concludes with identification of the treatment options including their relative advantages and limitations

Whole Blood for Transfusion (Release date 03/25/2019) The use of whole blood for transfusion is back primarily for massive hemorrhage. This course reviews the history of whole blood usage, the individual blood components that are normally isolated from it and studies designed to answer clinical questions regarding the use of whole blood today. 

The P Blood Group and Unexpected Anti-PP1Pk in an Eleven Week Old Infant (release date 08/21/2018). This course explores the history and biology of the P blood group and also includes a case study.

IgG Structure and Function
Effect on Hemolytic Disease of the Newborn and Neonatal Alloimmune Thrombocytopenia Severity
(Release Date: 05/07/2018) Hemolytic Disease of the Newborn (HDN) and Neonatal Alloimmune Thrombocytopenia (NAIT) pose significant morbidity and mortality risk.  Prevention and early detection are key.  Recent studies have described a correlation between immunoglobulin structure and clinical severity.  Typical IgG structure and immunoglobulin structural alterations along with the study results will be presented.

Indications for Transfusion (Release Date: 06/14/2017) Indications are established reasons for transfusion, which will benefit the patient. However blood components are drugs and can have adverse effects and should not be administered indiscriminately. This course will highlight the main indications and some of the adverse effects that can occur with the transfusion of red blood cells, plasma, and platelets.

Practical Coagulation for the Blood Bank (Release date: 06/30/2016) This course provides a summary of the general coagulation model which includes initiation, amplification and propagation. There is also a look at thrombin’s role in clot formation as well as a review of the common coagulation tests and the major drugs used in coagulation abnormalities.

An Introduction to Pathogen Reduction (Release date: 08/31/2016) This course defines the concept of pathogen reduction, describes the pathogen reduction systems available for blood components and summarizes the studies conducted to date.

FDA Draft Guidance on Platelet Safety (release date: 09/19/2017) This course reviews the significant elements of the FDA Draft Guidance on mitigation of bacterial contamination in platelets. This learning material also identifies the challenges for implementation of the proposed process changes and addresses how the Final Guidance may appear after public comments have been submitted and reviewed.

Last modified: Friday, March 27, 2020, 02:18 PM